EMEA-000181-PIP02-13-M01
Key facts
| Invented name |
Sativex
|
| Active substance |
|
| Therapeutic area |
Pain
|
| Decision number |
P/0373/2022
|
| PIP number |
EMEA-000181-PIP02-13-M01
|
| Pharmaceutical form(s) |
Oromucosal spray
|
| Condition(s) / indication(s) |
Treatment of pain
|
| Route(s) of administration |
Oromucosal use
|
| Contact for public enquiries |
GW Pharma Ltd
United Kingdom |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|